The promise of Immuno-oncology: implications for defining the value of cancer treatment

The promise of Immuno-oncology: implications for defining the value of cancer treatment

Abstract The rapid development of immuno-oncology (I-O) therapies for multiple types of cancer has transformed the cancer treatment landscape and brightened the long-term outlook for many patients with advanced cancer. Responding to ongoing efforts to generate value assessments for novel therapies,...

Full description

Bibliographic Details
Main Authors: Howard L. Kaufman, Michael B. Atkins, Prasun Subedi, James Wu, James Chambers, T. Joseph Mattingly, Jonathan D. Campbell, Jeff Allen, Andrea E. Ferris, Richard L. Schilsky, Daniel Danielson, J. Leonard Lichtenfeld, Linda House, Wendy K. D. Selig
Format: Article
Language:English
Published: BMJ Publishing Group 2019-05-01
Series:Journal for ImmunoTherapy of Cancer
Subjects:
Immunotherapy
Immuno-oncology
Value
Patient experience
Patient reported outcomes (PROs)
Online Access:http://link.springer.com/article/10.1186/s40425-019-0594-0

Internet

http://link.springer.com/article/10.1186/s40425-019-0594-0

Similar Items